Effect of Intravenous Ferric Carboxymaltose on Hemoglobin Response and Transfusion in Patients With Iron Deficiency Anemia After Off-Pump Coronary Artery Bypass Grafting
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT04898569
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT04898569
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT04898569. Randomized; single masking; primary purpose treatment. Start 2019-02-10 (actual); primary completion 2022-10-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Intravenous Ferric Carboxymaltose on Hemoglobin Response and Transfusion in Patients With Iron Deficiency Anemia After Off-Pump Coronary Artery Bypass Grafting
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Ferinject
- Intervention (Drug)
- Normal Saline Flush
- Lead sponsor
- Yonsei University
Record details
- Record id
cardio:ct-nct04898569- Content hash
bf366135e766aef6344cabc60bdb1c5ab488fafe71e7d7179ff6e77dc8c77b5d